Docetaxel (Taxotere) and gemcitabine (Gemzar) are active agents against breast cancer. Several phase I studies evaluated different schedules of their combination and clearly demonstrated that docetaxel and gemcitabine can
Vassilis A. Georgoulias, MD, PhD
Advertisement
Articles by Vassilis A. Georgoulias, MD, PhD
Advertisement
Latest Updated Articles
- Docetaxel/Gemcitabine: Salvage Chemotherapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Published: February 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves SC Pembrolizumab Formulation in Solid Tumors
2
Daratumumab Quadruplet Improves Efficacy in Transplant-Ineligible or-Deferred, Newly Diagnosed Myeloma
3
Sonrotoclax Combo Shows Safety, Promising Efficacy in R/R Multiple Myeloma
4
Belantamab Mafodotin Triplet Highlights Low Ocular Toxicity in Intermediate-Fit, Frail Newly Diagnosed Myeloma
5
